MA54563A - Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés de préparation et d'utilisation - Google Patents
Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés de préparation et d'utilisationInfo
- Publication number
- MA54563A MA54563A MA054563A MA54563A MA54563A MA 54563 A MA54563 A MA 54563A MA 054563 A MA054563 A MA 054563A MA 54563 A MA54563 A MA 54563A MA 54563 A MA54563 A MA 54563A
- Authority
- MA
- Morocco
- Prior art keywords
- silk
- preparing
- methods
- hyaluronic acid
- tissue fillers
- Prior art date
Links
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/0059—Cosmetic or alloplastic implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862781952P | 2018-12-19 | 2018-12-19 | |
| US201962865633P | 2019-06-24 | 2019-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54563A true MA54563A (fr) | 2022-03-30 |
Family
ID=71100930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054563A MA54563A (fr) | 2018-12-19 | 2019-12-19 | Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés de préparation et d'utilisation |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12296067B2 (fr) |
| EP (1) | EP3897564A4 (fr) |
| JP (1) | JP2022514349A (fr) |
| KR (1) | KR20210144660A (fr) |
| CN (1) | CN113677320A (fr) |
| AU (1) | AU2019405953B2 (fr) |
| BR (1) | BR112021012141A2 (fr) |
| CA (1) | CA3124196A1 (fr) |
| IL (1) | IL284082B2 (fr) |
| MA (1) | MA54563A (fr) |
| SG (1) | SG11202106411QA (fr) |
| WO (1) | WO2020132331A1 (fr) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230190997A1 (en) | 2017-06-26 | 2023-06-22 | Evolved By Nature, Inc. | Silk-hyaluronic acid based tissue filers and methods of using the same |
| US12296067B2 (en) | 2018-12-19 | 2025-05-13 | Evolved By Nature, Inc. | Silk-hyaluronic acid tissue fillers and methods of making and using the same |
| US20230108822A1 (en) * | 2020-02-06 | 2023-04-06 | Merz Pharma Gmbh & Co. Kgaa | Injectable composition for skin and soft tissue augmentation |
| WO2022155682A1 (fr) * | 2021-01-15 | 2022-07-21 | Trustees Of Tufts College | Biomatériaux à base de soie accordables avec substitutions de saccharides, et leurs procédés de production |
| TWI880094B (zh) | 2021-06-23 | 2025-04-11 | 德商莫茲製藥有限兩合公司 | 以絲蛋白交聯多醣及所得材料之用途 |
| KR102509832B1 (ko) * | 2022-02-23 | 2023-03-14 | 주식회사 지씨에스 | 상이한 구조를 이루는 다분산 펩타이드 기반의 최소 침습 임플란트가 가능한 하이드로겔 조성물 및 그의 용도 |
| WO2024126649A1 (fr) | 2022-12-15 | 2024-06-20 | Merz Pharma Gmbh & Co. Kgaa | Gel injectable comprenant de la toxine botulique et ses utilisations |
| KR102684411B1 (ko) | 2023-05-02 | 2024-07-11 | (재)씨젠의료재단 | 설포석신산-가교 히알루론산 및 생체 적합성 미립자를 포함하는 피부 필러 조성물, 및 그 제조방법 |
| KR102684409B1 (ko) | 2023-05-02 | 2024-07-11 | (재)씨젠의료재단 | 석신산-가교 히알루론산을 포함하는 피부 필러 조성물 및 그 제조방법 |
| KR20250079371A (ko) * | 2023-11-27 | 2025-06-04 | 조은애 | 친환경 용매를 사용한 생분해성 고분자 마이크로그래뉼이 융합된 히알루론산 겔을 포함하는 조직 수복용 주사제 조성물 및 그 제조 방법 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6630457B1 (en) | 1998-09-18 | 2003-10-07 | Orthogene Llc | Functionalized derivatives of hyaluronic acid, formation of hydrogels in situ using same, and methods for making and using same |
| DE60230907D1 (de) | 2001-10-25 | 2009-03-05 | Univ Connecticut | Fibroinzusammensetzungen und verfahren zu deren herstellung |
| EP1459728A4 (fr) | 2001-11-29 | 2005-04-20 | Nat Inst Of Agrobio Sciences | Emulsifiant et procede d'elaboration correspondant |
| US7632873B2 (en) | 2002-12-13 | 2009-12-15 | L'oreal S.A. | Cosmetic dermatological composition comprising at least one gradient copolymer, makeup comprising the cosmetic or dermatological composition and cosmetic method using the composition |
| WO2004067575A1 (fr) | 2003-01-31 | 2004-08-12 | Biosphere S.P.A. | Gels solubles et biocompatibles d'acide hyalonurique reticule avec des l-acides amines ou des l-aminoesters bifonctionnels |
| US7060260B2 (en) | 2003-02-20 | 2006-06-13 | E.I. Du Pont De Nemours And Company | Water-soluble silk proteins in compositions for skin care, hair care or hair coloring |
| US7115388B2 (en) | 2003-03-14 | 2006-10-03 | National Institute Of Agrobiological Sciences | Production of functional polypeptides originating from silk protein and use thereof |
| WO2005034852A2 (fr) | 2003-08-26 | 2005-04-21 | Gel-Del Technologies, Inc. | Biomateriaux et biocoacervats proteiniques, leurs procedes de fabrication et d'utilisation |
| WO2007041677A2 (fr) | 2005-10-03 | 2007-04-12 | Combinatorx, Incorporated | Implants de tissus mous et compositions de médicaments combinés, et leur utilisation |
| US8318695B2 (en) | 2007-07-30 | 2012-11-27 | Allergan, Inc. | Tunably crosslinked polysaccharide compositions |
| US8357795B2 (en) | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
| JP5123873B2 (ja) | 2009-02-20 | 2013-01-23 | 出光テクノファイン株式会社 | 繊維架橋体および繊維架橋体の製造方法 |
| JP2010213984A (ja) | 2009-03-18 | 2010-09-30 | Naisemu:Kk | 柔軟剤及び/又は保湿剤含有生体埋込用医療材料、該医療材料中の柔軟剤及び/又は保湿剤の含有量を調整する方法及び、該生体内埋込用医療材料の製造方法 |
| US20110189292A1 (en) * | 2009-04-20 | 2011-08-04 | Allergan, Inc. | Dermal fillers comprising silk fibroin hydrogels and uses thereof |
| US20120301441A1 (en) | 2009-11-11 | 2012-11-29 | Hermanus Bernardus Johannes Karperien | Dextran-hyaluronic acid based hydrogels |
| AU2015275313A1 (en) | 2010-11-08 | 2016-01-21 | Allergan Industrie, Sas | Hyaluronic acid based formulations |
| US9149422B2 (en) | 2011-06-03 | 2015-10-06 | Allergan, Inc. | Dermal filler compositions including antioxidants |
| US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
| KR20200116168A (ko) | 2011-09-14 | 2020-10-08 | 알러간, 인코포레이티드 | 잔주름 치료를 위한 진피 필러 조성물 |
| AU2012335122B2 (en) | 2011-11-09 | 2016-09-22 | Trustees Of Tufts College | Injectable silk fibroin foams and uses thereof |
| WO2013159101A1 (fr) | 2012-04-20 | 2013-10-24 | Trustees Of Tufts College | Compositions de soins personnels à base de fibroïne de soie |
| US20140023688A1 (en) | 2012-07-13 | 2014-01-23 | Firmenich Sa | Encapsulated oils |
| CN102836465B (zh) * | 2012-08-30 | 2014-06-04 | 浙江星月生物科技股份有限公司 | 一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用 |
| SG10201701773UA (en) * | 2012-09-06 | 2017-04-27 | Univ Nanyang Tech | Hyaluronic Acid-Based Drug Delivery Systems |
| WO2014055895A1 (fr) | 2012-10-05 | 2014-04-10 | Allergan, Inc. | Dispositif injectable et méthode de modelage, d'augmentation ou de correction de traits faciaux tels que du menton |
| BR112015007772B1 (pt) | 2012-10-08 | 2020-05-05 | Anteis Sa | formulação aquosa estéril injetável contendo ácido hialurônico reticulado e de hidroxiapatita para uso estético |
| US20140235554A1 (en) | 2013-02-12 | 2014-08-21 | Brian Lawrence | Ophthalmic formulation derived from silk protein |
| US11376329B2 (en) | 2013-03-15 | 2022-07-05 | Trustees Of Tufts College | Low molecular weight silk compositions and stabilizing silk compositions |
| US20140315828A1 (en) | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
| WO2014189780A2 (fr) | 2013-05-20 | 2014-11-27 | Tufts University | Appareil et procédé de formation d'un composite hydrogel à base de nanofibres |
| CA2920720A1 (fr) | 2013-08-20 | 2015-02-26 | Wake Forest University Health Sciences | Dispositifs de reparation tissulaire faisant appel a des materiaux auto-assembles |
| SG10201907426UA (en) * | 2013-09-30 | 2019-09-27 | Evolved By Nature Inc | Silk protein fragment compositions and articles manufactured therefrom |
| JP6369783B2 (ja) | 2014-06-12 | 2018-08-08 | 株式会社アーダン | 加水分解フィブロインを含む軟膏及びその製造方法 |
| WO2016115159A1 (fr) | 2015-01-12 | 2016-07-21 | Silk Therapeutics, Inc. | Compositions de fragment de protéine de soie conservées et articles |
| DK3288528T3 (da) | 2015-04-29 | 2021-04-06 | Evolved By Nature Inc | Silkebaserede fugtighedscremesammensætninger og fremgangsmåder deraf |
| FR3036035B1 (fr) | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
| CN104998302B (zh) | 2015-08-31 | 2017-11-24 | 中原工学院 | 一种以取向纳米纤维毡为骨架的纳米软骨修复材料及其制备方法 |
| TWI727014B (zh) | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
| EP3503841A4 (fr) * | 2016-08-24 | 2020-04-22 | Allergan, Inc. | Hydrogels co-réticulés d'acide hyaluronique-fibroïne pour améliorer la viabilité des greffes tissulaires et pour l'augmentation des tissus mous |
| US10857262B2 (en) | 2016-10-31 | 2020-12-08 | Sofregen Medical, Inc. | Compositions comprising low molecular weight silk fibroin fragments and plasticizers |
| CN106492279A (zh) * | 2016-11-04 | 2017-03-15 | 武汉纺织大学 | 一种丝素蛋白‑透明质酸复合凝胶的快速制备方法 |
| CN107880282B (zh) | 2016-12-29 | 2020-09-29 | 北京键凯科技股份有限公司 | 一种注射用多元甘醇环氧衍生物交联的透明质酸钠凝胶及其制备方法 |
| US20230190997A1 (en) | 2017-06-26 | 2023-06-22 | Evolved By Nature, Inc. | Silk-hyaluronic acid based tissue filers and methods of using the same |
| EP4169539B1 (fr) | 2017-06-26 | 2025-01-29 | Evolved by Nature, Inc. | Charges de tissu à base de soie-acide hyaluronique et leurs procédés d'utilisation |
| CN107619481B (zh) * | 2017-08-09 | 2020-08-14 | 浙江理工大学 | 一种利用桑蚕丝制备粘性丝素蛋白水凝胶的方法 |
| CN108392680B (zh) | 2018-02-09 | 2020-12-18 | 珠海睿展生物材料有限公司 | 一种可塑形全降解硬组织填充生物材料 |
| US12296067B2 (en) | 2018-12-19 | 2025-05-13 | Evolved By Nature, Inc. | Silk-hyaluronic acid tissue fillers and methods of making and using the same |
-
2019
- 2019-12-19 US US17/414,752 patent/US12296067B2/en active Active
- 2019-12-19 KR KR1020217022455A patent/KR20210144660A/ko active Pending
- 2019-12-19 AU AU2019405953A patent/AU2019405953B2/en active Active
- 2019-12-19 BR BR112021012141-2A patent/BR112021012141A2/pt not_active Application Discontinuation
- 2019-12-19 IL IL284082A patent/IL284082B2/en unknown
- 2019-12-19 WO PCT/US2019/067617 patent/WO2020132331A1/fr not_active Ceased
- 2019-12-19 CN CN201980092428.4A patent/CN113677320A/zh active Pending
- 2019-12-19 CA CA3124196A patent/CA3124196A1/fr active Pending
- 2019-12-19 EP EP19901148.7A patent/EP3897564A4/fr active Pending
- 2019-12-19 MA MA054563A patent/MA54563A/fr unknown
- 2019-12-19 SG SG11202106411QA patent/SG11202106411QA/en unknown
- 2019-12-19 JP JP2021535549A patent/JP2022514349A/ja active Pending
-
2024
- 2024-12-16 US US18/982,351 patent/US20250332322A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2022514349A (ja) | 2022-02-10 |
| KR20210144660A (ko) | 2021-11-30 |
| BR112021012141A2 (pt) | 2021-08-31 |
| IL284082B1 (en) | 2025-03-01 |
| US20250332322A1 (en) | 2025-10-30 |
| SG11202106411QA (en) | 2021-07-29 |
| AU2019405953B2 (en) | 2025-09-18 |
| CN113677320A (zh) | 2021-11-19 |
| AU2019405953A1 (en) | 2021-08-05 |
| EP3897564A4 (fr) | 2022-10-19 |
| IL284082B2 (en) | 2025-07-01 |
| IL284082A (en) | 2021-08-31 |
| EP3897564A1 (fr) | 2021-10-27 |
| US12296067B2 (en) | 2025-05-13 |
| US20230114250A1 (en) | 2023-04-13 |
| WO2020132331A1 (fr) | 2020-06-25 |
| CA3124196A1 (fr) | 2020-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA54563A (fr) | Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés de préparation et d'utilisation | |
| EP3645063A4 (fr) | Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation | |
| EP3746785A4 (fr) | Organoïdes associés à une immunothérapie et leurs procédés de préparation et d'utilisation | |
| EP4037695A4 (fr) | Compositions oligonucléotidiques et leurs procédés d'utilisation | |
| EP3958872A4 (fr) | Compositions d'oligonucléotides et leurs procédés d'utilisation | |
| EP3824096A4 (fr) | Nouveaux anticorps et leurs procédés de préparation et d'utilisation | |
| EP3775203A4 (fr) | Compositions d'oligonucléotides et leurs procédés d'utilisation | |
| EP3840730A4 (fr) | Compositions pour l'administration d'agents thérapeutiques et leurs méthodes d'utilisation et leurs procédés de préparation | |
| MA52753A (fr) | Anticorps anti-sirpa et leurs procédés d'utilisation | |
| EP3914651A4 (fr) | Compositions d'agrégats de carbonate et leurs procédés de préparation et d'utilisation | |
| MA45280A (fr) | Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation | |
| EP3645742A4 (fr) | Anticorps anti-ror1 et leurs procédés de préparation et d'utilisation | |
| MA55025A (fr) | Anticorps anti-trem2 et leurs procédés d'utilisation | |
| EP3493676A4 (fr) | Compositions antimicrobiennes à base de polymère et leurs procédés d'utilisation | |
| MA56191A (fr) | Inhibiteurs de l'autophagie à base d'amide d'aminopyrimidine et leurs procédés d'utilisation | |
| EP3826641A4 (fr) | Compositions d'anticorps anti-fcrn et leurs procédés d'utilisation | |
| EP3821012A4 (fr) | Véhicule d'administration à base de rétrotransposon et ses procédés d'utilisation | |
| EP3893767A4 (fr) | Instruments spécifiques à un patient et procédés d'utilisation | |
| EP3423421A4 (fr) | Ciments blancs à base de silicate de calcium carbonatable et leurs procédés de préparation et d'utilisation | |
| EP4034605A4 (fr) | Compositions de polissage et leurs procédés d'utilisation | |
| EP4048298A4 (fr) | Préparation et utilisation d'hydrogels thérapeutiques | |
| EP3994228A4 (fr) | Composition de silicone adhésive sensible à la pression et ses procédés de préparation et d'utilisation | |
| EP3836971A4 (fr) | Conjugués et leurs procédés d'utilisation | |
| MA53328A (fr) | Anticorps anti-siglec-5 et leurs procédés d'utilisation | |
| EP4045226A4 (fr) | Compositions de polissage et leurs procédés d'utilisation |